Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Celanese Corp
SIC 2820 · Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Celanese Corp
SIC 2820 · Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Celanese Corp
SIC 2820 · Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)
Notes
Support
about
terms
$
CE
Celanese Corp
CIK:
0001306830
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
Unaudited Interim Consolidated Statement of Operations - USD ($)
$ in Millions
3 Months Ended
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]
Net sales
$ 2,752
$ 2,532
$ 5,089
$ 4,921
Cost of sales
(2,134)
(1,998)
(4,003)
(3,913)
Gross profit
618
534
1,086
1,008
Selling, general and administrative expenses
(251)
(214)
(477)
(445)
Amortization of intangible assets
(39)
(42)
(79)
(82)
Research and development expenses
(29)
(31)
(57)
(62)
Other (charges) gains, net
(31)
(20)
(51)
(51)
Foreign exchange gain (loss), net
10
6
22
27
Gain (loss) on disposition of business and assets, net
(2)
(2)
46
1
Operating profit (loss)
276
231
490
396
Equity in net earnings (loss) of affiliates
11
29
46
51
Non-operating pension and other postretirement employee benefit (expense) income
5
1
10
3
Interest expense
(186)
(177)
(369)
(347)
Refinancing expense
0
0
0
32
Interest income
10
7
19
11
Dividend income - equity investments
43
41
44
42
Other income (expense), net
(17)
1
(16)
3
Earnings (loss) from continuing operations before tax
142
133
224
127
Income tax (provision) benefit
(11)
77
(44)
68
Earnings (loss) from continuing operations
131
210
180
195
Earnings (loss) from operation of discontinued operations
(2)
(10)
(3)
(16)
Income tax (provision) benefit from discontinued operations
0
0
0
1
Earnings (loss) from discontinued operations
(2)
(10)
(3)
(15)
Net earnings (loss)
129
200
177
180
Net (earnings) loss attributable to noncontrolling interests
(4)
(3)
(8)
(7)
Net earnings (loss) attributable to Celanese Corporation
125
197
169
173
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations
127
207
172
188
Earnings (loss) from discontinued operations
(2)
(10)
(3)
(15)
Net earnings (loss)
$ 125
$ 197
$ 169
$ 173
Earnings (loss) per common share - basic
Continuing operations - basic (in dollars per share)
$ 1.16
$ 1.89
$ 1.57
$ 1.72
Discontinued operations - basic (in dollars per share)
(0.02)
(0.09)
(0.03)
(0.14)
Net earnings (loss) - basic (in dollars per share)
1.14
1.80
1.54
1.58
Earnings (loss) per common share - diluted
Continuing operations - diluted (in dollars per share)
1.15
1.89
1.56
1.71
Discontinued operations - diluted (in dollars per share)
(0.02)
(0.09)
(0.02)
(0.13)
Net earnings (loss) - diluted (in dollars per share)
$ 1.13
$ 1.80
$ 1.54
$ 1.58
Weighted average shares - basic (in shares)
109,776,090
109,526,113
109,720,324
109,473,864
Weighted average shares - diluted (in shares)
110,249,548
109,734,396
110,095,824
109,686,840
v3.26.1
Unaudited Interim Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating Activities
Net earnings (loss)
$ 177
$ 180
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities
Depreciation, amortization and accretion
457
384
Pension and postretirement net periodic benefit cost
(5)
4
Pension and postretirement contributions
(26)
(27)
Deferred income taxes, net
(70)
(44)
(Gain) loss on disposition of businesses and assets, net
47
2
Stock-based compensation
18
12
Undistributed earnings in unconsolidated affiliates
24
2
Other, net
1
40
Operating cash provided by (used in) discontinued operations
(13)
8
Changes in operating assets and liabilities
Trade receivables - third party and affiliates, net
(399)
(31)
Inventories
(103)
115
Other assets
(58)
104
Trade payables - third party and affiliates
228
38
Other liabilities
101
(336)
Net cash provided by (used in) operating activities
285
447
Investing Activities
Capital expenditures on property, plant and equipment
(128)
(195)
Proceeds from sale of businesses and assets, net
(493)
(7)
Other, net
1
2
Net cash provided by (used in) investing activities
366
(186)
Financing Activities
Net change in short-term borrowings with maturities of 3 months or less
11
1
Proceeds from short-term borrowings
29
589
Repayments of short-term borrowings
(43)
(555)
Proceeds from long-term debt
96
2,821
Repayments of long-term debt
(621)
(2,833)
Common stock dividends
(6)
(6)
Distributions/dividends to noncontrolling interests
(14)
(14)
Other, net
(1)
(74)
Net cash provided by (used in) financing activities
(549)
(71)
Exchange rate effects on cash and cash equivalents
(1)
21
Net increase (decrease) in cash and cash equivalents
101
211
Cash and cash equivalents as of beginning of period
1,263
962
Cash and cash equivalents as of end of period
$ 1,364
$ 1,173
v3.26.1
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Current Assets
Cash and cash equivalents
$ 1,364
$ 1,263
Trade receivables - third party and affiliates
1,288
922
Non-trade receivables, net
581
545
Inventories
2,305
2,220
Assets held for sale
0
492
Other assets
257
251
Total current assets
5,795
5,693
Investments in affiliates
1,233
1,252
Property, plant and equipment, net
4,807
5,076
Operating lease right-of-use assets
417
359
Deferred income taxes
1,325
1,359
Other assets
605
601
Goodwill
[1]
4,151
4,171
Intangible assets, net
3,075
3,184
Total assets
21,408
21,695
Current Liabilities
Short-term borrowings and current installments of long-term debt - third party and affiliates
1,311
1,204
Trade payables - third party and affiliates
1,485
1,279
Liabilities held for sale
0
75
Other liabilities
1,106
1,049
Income taxes payable
104
76
Total current liabilities
4,006
3,683
Long-term debt, net of unamortized deferred financing costs
10,696
11,394
Deferred income taxes
458
512
Uncertain tax positions
211
208
Benefit obligations
321
344
Operating lease liabilities
317
265
Other liabilities
811
817
Commitments and Contingencies
Shareholders' Equity
Common stock, $0.0001 par value, 400,000,000 shares authorized (2026: 171,036,104 issued and 2025: 170,918,221 issued)
0
0
Treasury stock, at cost
(5,480)
(5,482)
Additional paid-in capital
450
431
Retained earnings
10,039
9,876
Accumulated other comprehensive income (loss), net
(842)
(776)
Total Celanese Corporation shareholders' equity
4,167
4,049
Noncontrolling interests
421
423
Total equity
4,588
4,472
Total liabilities and equity
$ 21,408
$ 21,695
[1]
Includes accumulated impairment losses of $2.7 billion in the Engineered Materials segment.